| __timestamp | Corcept Therapeutics Incorporated | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 50829000 |
| Thursday, January 1, 2015 | 36949000 | 57305000 |
| Friday, January 1, 2016 | 45240000 | 116145000 |
| Sunday, January 1, 2017 | 62416000 | 159362000 |
| Monday, January 1, 2018 | 81289000 | 206366000 |
| Tuesday, January 1, 2019 | 100359000 | 228244000 |
| Wednesday, January 1, 2020 | 105326000 | 293355000 |
| Friday, January 1, 2021 | 122356000 | 401715000 |
| Saturday, January 1, 2022 | 152848000 | 459856000 |
| Sunday, January 1, 2023 | 184259000 | 542705000 |
| Monday, January 1, 2024 | 492128000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, effective cost management is crucial for sustained growth. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Exelixis, Inc. and Corcept Therapeutics Incorporated from 2014 to 2023. Over this period, Exelixis, Inc. has seen a staggering 967% increase in SG&A expenses, reflecting its aggressive expansion and investment in operational capabilities. Meanwhile, Corcept Therapeutics has experienced a 428% rise, indicating a more measured approach to scaling its operations.
These trends underscore the distinct strategies of these biotech players in managing operational costs.
Novo Nordisk A/S vs Corcept Therapeutics Incorporated: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Exelixis, Inc.
Cost Management Insights: SG&A Expenses for Incyte Corporation and Corcept Therapeutics Incorporated
Exelixis, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Exelixis, Inc. and Merus N.V.
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and HUTCHMED (China) Limited
Comparing SG&A Expenses: Exelixis, Inc. vs Novavax, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and MiMedx Group, Inc.
Corcept Therapeutics Incorporated and Perrigo Company plc: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
SG&A Efficiency Analysis: Comparing Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.